January/February 2017 | business Of Retinainnovations In Retina
Tie Fighters
Targeting Tie-2 in patients with wet AMD or diabetic eye disease could allow clinicians to treat patients who have not responded to conventional therapies.
Aron Shapiro; David Hollander, MD; and Lisa Smith